Search

Showing "11155" results for ""

New directions in HIV prevention: serosorting and universal testing

Five cancers seen in vicriviroc study `not causally related`, study continues

Treatment started early in HIV infection effective and well tolerated for up to five years

Genotypic resistance testing on a failing regimen is possible below 1000 copies/ml

Co-packaged AZT/3TC/efavirenz regimen approved for use in PEPFAR programmes

Ethiopia to provide ARVs to 50,000 by July

Vitamin A supplementation fails to reduce mother-to-child transmission of HIV, may even harm infants exposed to HIV via breast milk

The high cost of non-antiretroviral medicines used by people with AIDS in Côte d’Ivoire

Low bone mineral density a risk for HIV-positive women in middle age

Tenofovir vaginal gel safe and well tolerated

Prevention alongside treatment only way to contain HIV epidemic, scientific modelling finds

Proteins can help cells protect themselves from infection with HIV

US launches drive to find better HIV treatments for children in poorest countries

Atazanavir/ritonavir as potent over two years as Kaletra, but has better side-effects profile

Study finds evidence linking fat loss to the activity of the nervous system

CD8 T-cells only kill a fifth of the HIV-infected CD4 T-cells

Treatment interruption arm of DART study halted

Management of HIV and hepatitis B or C co-infection in resource-limited settings

Receive the latest HIV research and conference news

Showing "11155" results for ""

New directions in HIV prevention: serosorting and universal testing

Five cancers seen in vicriviroc study `not causally related`, study continues

Treatment started early in HIV infection effective and well tolerated for up to five years

Genotypic resistance testing on a failing regimen is possible below 1000 copies/ml

Co-packaged AZT/3TC/efavirenz regimen approved for use in PEPFAR programmes

Ethiopia to provide ARVs to 50,000 by July

Vitamin A supplementation fails to reduce mother-to-child transmission of HIV, may even harm infants exposed to HIV via breast milk

The high cost of non-antiretroviral medicines used by people with AIDS in Côte d’Ivoire

Low bone mineral density a risk for HIV-positive women in middle age

Tenofovir vaginal gel safe and well tolerated

Prevention alongside treatment only way to contain HIV epidemic, scientific modelling finds

Proteins can help cells protect themselves from infection with HIV

US launches drive to find better HIV treatments for children in poorest countries

Atazanavir/ritonavir as potent over two years as Kaletra, but has better side-effects profile

Study finds evidence linking fat loss to the activity of the nervous system

CD8 T-cells only kill a fifth of the HIV-infected CD4 T-cells

Treatment interruption arm of DART study halted

Management of HIV and hepatitis B or C co-infection in resource-limited settings

Receive the latest HIV research and conference news